In addition, numerous very well proven adverse prognostic markers, such as U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, lost their detrimental impact in people taken care of with VO. The only real issue that remained predictive of the shorter development-cost-free survival During this cohort of individuals was TP53 aberrations.112 Eventually,